Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder
- PMID: 33974052
- PMCID: PMC8372665
- DOI: 10.1210/clinem/dgab327
Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder
Abstract
Context: Primary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the general population has not been studied.
Objective: To estimate the incidence of PA in the general population.
Design and methods: Patients who had received a diagnostic code for PA between 1987 and 2016 were identified in the Swedish National Patient Registry. Assessment of clinical and biochemical data was used to validate the diagnosis. The annual incidence of PA was calculated by using the number of inhabitants in the Västra Götaland County as a reference.
Results: Of 570 identified patients, 473 (83%) had confirmed PA. Eligible for the incidence analysis were 416 patients, 248 (60%) men and 168 (40%) women, diagnosed with PA between 1987 and 2016. The mean (± standard deviation) age at diagnosis was 56 ± 12 years. The median (interquartile range) annual incidence was 2 (1-2) cases per million between 1987 and 1996, 6 (4-9) cases per million between 1997 and 2006 and 17 (12-24) cases per million between 2007 and 2016. At the end of the study (December 31, 2016), 386 patients with confirmed PA were alive and living in the Västra Götaland County, giving a prevalence of 231 cases per million (0.022%).
Conclusions: Despite increasing incidence, the proportion of patients identified with PA is lower than expected. Given the serious consequences of untreated PA, the noticeably low prevalence at the end of the study stresses the need to increase the awareness of PA among health care providers.
Keywords: epidemiology; incidence; prevalence; primary aldosteronism.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
Comment in
-
Letter to the Editor From Singhania et al: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades-Yet an Underdiagnosed Disorder".J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1315-e1316. doi: 10.1210/clinem/dgab804. J Clin Endocrinol Metab. 2022. PMID: 34734261 No abstract available.
-
Response to Letter to the Editor From Singhania et al.: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet an Underdiagnosed Disorder".J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1325-e1326. doi: 10.1210/clinem/dgab805. J Clin Endocrinol Metab. 2022. PMID: 34734266 Free PMC article. No abstract available.
References
-
- Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies–a review of the current literature. Horm Metab Res. 2012;44(3):157-162. - PubMed
-
- Rossi GP, Bernini G, Caliumi C, et al. ; PAPY Study Investigators . A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293-2300. - PubMed
-
- Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21(4):315-318. - PubMed
-
- Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921-1926. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
